Large‐scale multiplex polymerase chain reaction assay for diagnosis of viral reactivations after allogeneic hematopoietic stem cell transplantation
暂无分享,去创建一个
M. Nojima | H. Tsutsumi | T. Hori | Y. Yoto | N. Hatakeyama | Masaki Yamamoto | N. Suzuki | N. Shimizu | N. Inazawa
[1] Human Herpesvirus , 2016, Red Book Atlas of Pediatric Infectious Diseases, 3rd Ed.
[2] P. Lewalle,et al. Detection of Herpesviridae in Whole Blood by Multiplex PCR DNA-Based Microarray Analysis after Hematopoietic Stem Cell Transplantation , 2014, Journal of Clinical Microbiology.
[3] W. Jędrzejczak,et al. Co-Infections with Cytomegalovirus and Human Herpesvirus Type 7 in Adult Polish Allogeneic Haematopoietic Stem Cell Transplant Recipients , 2013, Archivum Immunologiae et Therapiae Experimentalis.
[4] I. Yakoub-Agha,et al. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[5] D. Weisdorf,et al. Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary? , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[6] A. Skotnicki,et al. Lymphotropic herpesvirus DNA detection in patients with active CMV infection – a possible role in the course of CMV infection after hematopoietic stem cell transplantation , 2011, Medical science monitor : international medical journal of experimental and clinical research.
[7] Jing-bo Wang,et al. [Monitoring of early Epstein-Barr virus reactivation and preemptive therapy after allogeneic hematopoietic stem cell transplantation]. , 2011, Zhonghua nei ke za zhi.
[8] P. Chevallier,et al. Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation , 2011, Leukemia.
[9] D. Duda,et al. Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation. , 2010, Transplantation proceedings.
[10] I. Kerridge,et al. Pre‐transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy , 2010, Transplant infectious disease : an official journal of the Transplantation Society.
[11] P. Chevallier,et al. Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source , 2010, Bone Marrow Transplantation.
[12] P. O’Donnell,et al. BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[13] A. Guimarães,et al. Association between oral HSV-1 and survival in allogeneic hematopoietic stem cell transplanted patients. , 2009, Medicina oral, patologia oral y cirugia bucal.
[14] D. van Baarle,et al. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[15] A. Lankester,et al. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning , 2007, European journal of haematology.
[16] P. Lusso. HHV-6 and the immune system: mechanisms of immunomodulation and viral escape. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[17] K. Kashima,et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. , 2006, The Journal of infectious diseases.
[18] M. Boeckh,et al. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] S. Chevret,et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. , 2004, Experimental hematology.
[20] K. Yamanishi,et al. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. , 2002, Blood.
[21] J Wagner,et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. , 2002, Blood.
[22] E. Jaffe,et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. , 1999, Blood.
[23] J. Peiris,et al. Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group. , 1995, Bone marrow transplantation.
[24] J. Peiris,et al. Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group. , 1995, Bone marrow transplantation.
[25] W W Wilke,et al. Multiplex polymerase chain reaction. , 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.